title: Successful control of steroid-intolerant Evans' syndrome associated with allogeneic peripheral blood hematopoietic stem cell transplant by rituximab.
authors.forename: Se
authors.initials: S
authors.lastname: Ryeon Lee
authors.forename: Suk-Young
authors.initials: SY
authors.lastname: Lee
authors.forename: Myung-Hyun
authors.initials: MH
authors.lastname: Nam
authors.forename: Yong
authors.initials: Y
authors.lastname: Park
authors.forename: Seh
authors.initials: S
authors.lastname: Jong Park
authors.forename: Hwa
authors.initials: H
authors.lastname: Jung Sung
authors.forename: Chul
authors.initials: C
authors.lastname: Won Choi
authors.forename: Byung
authors.initials: B
authors.lastname: Soo Kim
mesh_terms: D000293:Adolescent; D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy / Q000209:etiology; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D004342:Drug Hypersensitivity / Q000188:drug therapy*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000628:therapy; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects*; D000069283:Rituximab; D013256:Steroids / Q000009:adverse effects*; D013921:Thrombocytopenia / Q000188:drug therapy / Q000209:etiology; D014184:Transplantation, Homologous; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D013256:Steroids; D000069283:Rituximab